The National Cancer Institute (NCI) is offering grants for innovative molecular and cellular analysis technologies focused on basic and clinical cancer research. This grant aims to support the development of novel capabilities that target molecular and cellular features of cancer biology. The funded projects should accelerate research in cancer biology, early detection, diagnosis, treatment, and address cancer health disparities. Applications must propose highly innovative technologies with the potential for widespread applicability while enhancing cancer research. This opportunity is part of the NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Closing date for applications is September 28, 2018.
Opportunity ID: 298876
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-18-002 |
| Funding Opportunity Title: | Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 – Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 17 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 20, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 28, 2018 |
| Current Closing Date for Applications: | Sep 28, 2018 |
| Archive Date: | Nov 03, 2018 |
| Estimated Total Program Funding: | $4,200,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Independent school districts City or township governments Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) County governments For profit organizations other than small businesses Special district governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer biology. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-002.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00236458 | Jan 28, 2018 | Sep 28, 2018 | View |
Package 1
Mandatory forms
298876 RR_SF424_2_0-2.0.pdf
298876 PHS398_CoverPageSupplement_4_0-4.0.pdf
298876 RR_OtherProjectInfo_1_4-1.4.pdf
298876 PerformanceSite_2_0-2.0.pdf
298876 RR_KeyPersonExpanded_2_0-2.0.pdf
298876 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
298876 RR_Budget_1_4-1.4.pdf
298876 RR_SubawardBudget30_1_4-1.4.pdf
298876 PHS398_ModularBudget_1_2-1.2.pdf
298876 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
